Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-25 Sale |
2022-05-26 5:17 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
14,715 | $150.51 | $2,214,819 | 76,532 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 9:14 pm |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
2,000 | $198.03 | $396,060 | 1,457 (Direct) |
View |
| 2021-11-18 Sale |
2021-11-19 4:45 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
17,355 | $276.85 | $4,804,674 | 197,294 (Direct) |
View |
| 2021-11-10 Sale |
2021-11-12 5:12 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
4,783 | $263.93 | $1,262,355 | 91,247 (Direct) |
View |
| 2021-11-02 Sale |
2021-11-04 5:45 pm |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
2,285 | $295.87 | $676,070 | 12,337 (Direct) |
View |
| 2021-11-02 Sale |
2021-11-04 5:41 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,400 | $303.94 | $729,467 | 91,247 (Direct) |
View |
| 2021-10-29 Sale |
2021-11-02 5:07 pm |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,645 | $288.2 | $474,085 | 1,547 (Direct) |
View |
| 2021-09-14 Sale |
2021-09-15 5:46 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
274 | $294.26 | $80,628 | 93,647 (Direct) |
View |
| 2021-09-09 Sale |
2021-09-13 6:24 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
25,000 | $294.75 | $7,368,650 | 214,649 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-02 4:33 pm |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
3,377 | $285.33 | $963,559 | 33,318 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-02 4:29 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
3,459 | $283.91 | $982,058 | 93,921 (Direct) |
View |
| 2021-08-30 Sale |
2021-09-02 06:54 am |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,001 | $282.13 | $1,128,802 | 17,354 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-19 4:42 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
18,956 | $254.18 | $4,818,219 | 93,921 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-26 Option Award |
2022-05-31 8:23 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | Konstantinov Konstantin Director |
4,330 | $0 | 4,330 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 8:21 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
2,209 | $0 | 78,741 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 8:20 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,832 | $0 | 3,379 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 8:17 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | MUIR GLENN P Director |
1,832 | $0 | 8,194 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 8:15 pm |
2023-05-26 2032-05-26 |
REPLIGEN CORP | RGEN | EGLINTON MANNER CARRIE Director |
3,512 | $0 | 3,969 (Direct) |
View |
| 2022-05-13 Tax Withholding |
2022-05-17 5:00 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
712 | $150.4 | 20,110 (Direct) |
View |
| 2022-05-13 Tax Withholding |
2022-05-17 4:59 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
335 | $150.4 | 34,092 (Direct) |
View |
| 2022-05-13 Tax Withholding |
2022-05-17 4:59 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
712 | $150.4 | 39,187 (Direct) |
View |
| 2022-04-01 Tax Withholding |
2022-04-04 5:57 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
335 | $188.02 | 9,733 (Direct) |
View |
| 2022-03-08 Exercise |
2022-03-09 8:02 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
1,214 | $59.52 | 56,180 (Direct) |
View |
| 2022-03-08 Exercise |
2022-03-09 8:02 pm |
N/A 2028-03-01 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
4,166 | $0 | 56,180 (Direct) |
View |
| 2022-03-08 Exercise |
2022-03-09 8:02 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
2,952 | $33.87 | 56,180 (Direct) |
View |
| 2022-03-01 Tax Withholding |
2022-03-03 3:52 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
7,292 | $194.06 | 199,315 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-02 9:14 pm |
N/A N/A |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,000 | $38.76 | 1,457 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-02 9:14 pm |
N/A 2030-11-11 |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,000 | $0 | 1,457 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 8:19 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
2,534 | $196.7 | 20,822 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 8:19 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,234 | $0 | 20,822 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 7:52 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
3,824 | $196.7 | 35,733 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 7:52 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
5,922 | $0 | 35,733 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 7:49 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
19,292 | $196.7 | 206,607 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 7:49 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
30,074 | $0 | 206,607 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 7:47 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
1,060 | $196.7 | 34,427 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 8:04 pm |
N/A 2032-02-24 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
36,162 | $0 | 216,132 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 8:04 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
1,170 | $189.21 | 216,132 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:10 pm |
N/A 2032-02-24 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
7,853 | $0 | 38,045 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 7:10 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
269 | $189.21 | 38,045 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:10 pm |
N/A 2032-02-24 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
4,849 | $0 | 21,845 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 7:10 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
188 | $189.21 | 21,845 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:09 pm |
N/A 2032-02-24 |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
4,845 | $0 | 38,208 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 7:09 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
181 | $189.21 | 38,208 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:07 pm |
N/A 2032-02-24 |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
7,678 | $0 | 14,380 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 7:07 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
188 | $189.21 | 14,380 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 7:37 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
900 | $0 | 6,890 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 7:37 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer |
334 | $182.42 | 6,890 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 7:34 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
450 | $0 | 17,184 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 7:34 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
175 | $182.42 | 17,184 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 7:31 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
450 | $0 | 33,544 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 7:31 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Gebski Christine See Remarks |
224 | $182.42 | 33,544 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 7:30 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
900 | $0 | 30,461 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 7:30 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
332 | $182.42 | 30,461 (Direct) |
View |
| 2021-12-14 Tax Withholding |
2021-12-15 9:30 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
445 | $252.53 | 16,909 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-19 4:45 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
10,000 | $32.4 | 197,294 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-19 4:45 pm |
N/A 2027-02-23 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
10,000 | $0 | 197,294 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 5:12 pm |
N/A N/A |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
4,783 | $26.12 | 91,247 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 5:12 pm |
N/A 2026-05-11 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
4,783 | $0 | 91,247 (Direct) |
View |
| 2021-11-02 Exercise |
2021-11-04 5:45 pm |
N/A 2030-05-13 |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,285 | $0 | 12,337 (Direct) |
View |
| 2021-11-02 Exercise |
2021-11-04 5:45 pm |
N/A N/A |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
1,285 | $128.18 | 12,337 (Direct) |
View |
| 2021-10-29 Exercise |
2021-11-02 5:07 pm |
N/A 2030-05-13 |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,285 | $0 | 1,547 (Direct) |
View |
| 2021-10-29 Exercise |
2021-11-02 5:07 pm |
N/A N/A |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,285 | $128.18 | 1,547 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 6:24 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
25,000 | $32.4 | 214,649 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 6:24 pm |
N/A 2027-02-23 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
25,000 | $0 | 214,649 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 4:29 pm |
N/A N/A |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
3,459 | $38.76 | 93,921 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-02 4:29 pm |
N/A 2027-05-18 |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
3,459 | $0 | 93,921 (Direct) |
View |
| 2021-08-17 Gift |
2021-08-18 4:16 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
1,000 | $0 | 189,495 (Direct) |
View |